N
Nina Drize
Researcher at Russian Academy
Publications - 107
Citations - 520
Nina Drize is an academic researcher from Russian Academy. The author has contributed to research in topics: Bone marrow & Haematopoiesis. The author has an hindex of 12, co-authored 97 publications receiving 461 citations. Previous affiliations of Nina Drize include Russian Academy of Sciences & Moscow State University.
Papers
More filters
Journal ArticleDOI
Alterations in hematopoietic microenvironment in patients with aplastic anemia.
Irina N. Shipounova,Tatiana V. Petrova,D. A. Svinareva,Kira S. Momotuk,E A Mikhailova,Nina Drize +5 more
TL;DR: The data suggest that the physiological activation of the stromal microenvironment is characteristic of AA, and abnormal regulatory patterns in both osteoblastic and vascular contexts are found.
Journal ArticleDOI
Overexpression in Escherichia coli and purification of human fibroblast growth factor (FGF-2).
Marine E. Gasparian,P. A. Elistratov,Nina Drize,I. N. Nifontova,Dmitry A. Dolgikh,Mikhail P. Kirpichnikov +5 more
TL;DR: In this article, the human FGF-2 gene (encoding residues 1-155) was synthesized by PCR from 20 oligonucleotides and cloned into plasmid pET-32a.
Journal ArticleDOI
Reactive oxygen species produced in mitochondria are involved in age-dependent changes of hematopoietic and mesenchymal progenitor cells in mice. A study with the novel mitochondria-targeted antioxidant SkQ1.
Irina N. Shipounova,D. A. Svinareva,T.V. Petrova,Konstantin G. Lyamzaev,Boris V. Chernyak,Nina Drize,Vladimir P. Skulachev +6 more
TL;DR: The data indicate that the stromal environment of hematopoietic cells could be the primary target of age-dependent changes mediated by reactive oxygen species produced in mitochondria.
Journal ArticleDOI
Long-Term Maintenance of Hematopoiesis in Irradiated Mice by Retrovirally Transduced Peripheral Blood Stem Cells
TL;DR: It is concluded that long-term marrow repopulating cells mobilized into circulation by treatment with granulocyte colony-stimulating factor (G-CSF ) and stem cell factor (SCF ) are capable of maintaining lifelong polyclonal hematopoiesis in reconstituted mice.
Journal ArticleDOI
The Results of the Russian Clinical Trial of Mesenchymal Stromal Cells (MSCs) in Severe Neutropenic Patients (pts) with Septic Shock (SS) (RUMCESS trial)
Gennadii M. Galstian,Elena N. Parovichnikova,Polina M. Makarova,Larisa A. Kuzmina,Vera V. Troitskaya,Eduard G. Gemdzhian,Nina Drize,Valeri G. Savchenko +7 more
TL;DR: The significant increase in 28 days OS of the pts in CT+MCSs group was associated with SOFA score decrease, which was started in three days after onset of SS, but does not prevent death from sepsis-related organ dysfunction in long term.